Twitter Beğeni Hilesi

Meet Gary Maartens, Professor of Medicine at the University of Cape Town (#UCT) -- a global leader in #tuberculosis and HIV #research. Their Division of Clinical Pharmacology has conducted phase 2/3 studies in #TB and #HIV for over 20 year! Learn more: bit.ly/3VfV1fR

New research shows early self-reported adherence to #HCV treatment could help identify those at higher risk of treatment failure. Full adherence associated with higher sustained virologic response rates: bit.ly/412UMWA #ACTG #A5360 #MINMONTrial

Today is HIV Vaccine Awareness Day, a day to recognize the volunteers, community members, and researchers working to find a safe and effective vaccine to prevent #HIV. Such a vaccine, along w/ existing HIV treatment and prevention strategies, would help to #EndHIVEpidemic. #HVAD

May 19 is National Asian & Pacific Islander HIV/AIDS Awareness Day, a day to combat stigma in Asian and Pacific Islander communities. When we reduce HIV stigma and promote prevention, testing, and treatment, we can #StopHIVTogether. bit.ly/3ZU99wK #NAPIHAAD #APIMay19

An #ACTG #clinicaltrial may study experimental medications to treat #HIV and #AIDS, or to prevent or treat HIV-related infections.

Meet Anne Njoroge, a CAB member for Eldoret-Kenya. She has been educating Kenyans about the importance of research, HIV prevention, and the elimination of HIV-related stigma and discrimination since 2010. Learn more here: bit.ly/3VfV1fR #eldoretkenya #CAB #EndingHIV

In 2021, approximately 650,000 people died from HIV-related causes and 1.5 million people acquired HIV. Learn more facts here: bit.ly/3mYYIdj #HIVfacts #EndHIV #WHO

Meet Dr. Kristine Erlandson, an Associate Professor of Medicine in the Division of Infectious Diseases at the University of Colorado. Dr. Erlandson has been actively involved in the #ACTG since she was an infectious diseases fellow. Learn more: bit.ly/3VfV1fR

Welcome to our new website! View our new anthem video and others that illustrate the scientific and human impact of our work. Learn about our commitment to using team science and patient engagement to build bridges to biomedical breakthroughs. Explore now: fnih.org

The #AASLD / #IDSA updated evidence-based guidance on #HCV infection diagnosis, management & treatment. From universal screening to management in unique populations, their latest update covers it all. #HEPC #HepatitisC

Learn what can happen when great minds come together to advance science. Our new video highlights the extraordinary efforts of Accelerating #COVID19 Therapeutic Interventions and Vaccines (ACTIV), setting a framework for future preparedness and response. lnkd.in/dUjiAPKw

Exciting week ahead as the AIDS Clinical Trials Group 2023 meeting kicks off from June 13-16! Researchers and community members from around the world coming together to advance HIV research and treatments. Follow #ACTG2023 for updates! #HIV #clinicaltrials #researchmatters

Exciting update from Dr. Currier on the state of the ACTG, highlighting a year of achievements. Stay tuned for more groundbreaking research! #ACTG #HIVresearch #scientificprogress #ACTG2023 #TB #HBV Judith currier

Cheers to the 2023 ACTG Network Award recipients - Fredrick Sawe, Kimberly Scarsi, Rosie Mngqibisa, and Raphael Landovitz! Your exceptional dedication to #HIV #research and patient care is truly commendable. #ACTG2023

Check out the new website from ACTG and experience a community-focused and user-friendly platform. #ACTG #HIVresearch #clinicaltrials #ACTG2023 actgnetwork.org

While U.S. health agencies watch for a potential mpox rebound this summer, here’s a brief look at how the ACTG Network launched a study on mpox treatment. #clinicaltrials #mpox ms.spr.ly/6016gsUcp

National #HIVTestingDay is June 27. No matter how you test, no matter your test results, you can take the next step for your health. Learn more about HIV testing options: bit.ly/3LVPmav. #StopHIVTogether

Kneeshe Parkinson, founder of RISE Impact a motivational speaker, certified life coach, trainer, facilitator, #activist, and The Washington University AIDS Clinical Trial Unit Community Advisory Board (#CAB) member featured in the current issue of #POZ bit.ly/3ro2yOY

Join the #ACTG CSS! Applications open for 2023 membership. Seeking qualified individuals from U.S. and non-US sites. Focus on Western Hemisphere for equitable representation. Apply now! #HIVresearch Learn more here: bit.ly/3DaFHsE

📢 Exciting news from #ACTG! 🌍 They've published “Pitavastatin to Prevent Cardiovascular Disease in HIV Infection” in #NEJM. The #REPRIEVE trial shows pitavastatin calcium cuts risk of cardiovascular events by 35% in HIV patients over 5 years. #IAS2023 bit.ly/3OsgNLK